Clinical Trial Update: A Phase III Clinical Trial of High-dose Rituximab (500mg/m²) Combined With CHOP Regimen in the Treatment of Male Patient With Newly Diagnosed Advanced DLBCL [Phase 3]

View source ↗

Summary

A Phase III clinical trial evaluating high-dose rituximab with CHOP as first-line therapy for newly diagnosed advanced diffuse large B-cell lymphoma; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Rituximab (rituximab)
• Vincristine (vincristine)

Snippet

Sponsor: Xia Yi | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 3 | Status: NOT_YET_RECRUITING